Furthermore, ALDH1A1 overexpression was associated with poor prognosis in patients subgroups stratified by tumor size, depth invasion and lymph node metastasis. This evidence concerns the gene ALDH1A1 and metastatic malignant neoplasm in the lymph nodes.